Sheridan, David - Plymouth University

个人简介

Role Dr Sheridan is Associate Professor in Hepatology at the Institute of Translational & Stratified Medicine, Plymouth University Peninsula Schools of Medicine & Dentistry and Honorary consultant hepatologist at the South West Liver Unit, Derriford Hospital. Research interests are chronic hepatitis C virus, metabolism and non-alcoholic fatty liver disease. Qualifications Qualifications: BSc Immunology & Cell Pathology, University College London 1997 MB BS Royal Free & University College London Medical School 2000 (with distinction) MRCP(UK) 2003 PhD Newcatle University 2010

研究领域

Hepatitis C Virus Lipid metabolism Non-alcoholic fatty liver disease Mitochondrial bioenergetics Clinical Trials

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Eslam M, Mangia A, Berg T, Chan HLY, Irving WL, Dore GJ, Abate ML, Bugianesi E, Adams LA & Najim MAM 2016 'Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes' Hepatology (Baltimore, Md.) 64, (1) 34-46 , DOI PEARL Eslam M, Hashem AM, Romero-Gomez M, Berg T, Dore GJ, Mangia A, Chan HLY, Irving WL, Sheridan D & Abate ML 2016 'FibroGENE: A gene-based model for staging liver fibrosis' Journal of hepatology 64, (2) 390-398 , DOI Bassendine MF, Nielsen SU, Bridge SH, Felmlee DJ, Sheridan DA, Packard CJ & Neely RD 2016 'Hepatitis C virus and atherosclerosis: A legacy after virologic cure?' Clinics and research in hepatology and gastroenterology , DOI Sheridan DA, Hajarizadeh B, Fenwick FI, Matthews GV, Applegate T, Douglas M, Neely D, Askew B, Dore GJ & Lloyd AR 2016 'Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection' Liver international : official journal of the International Association for the Study of the Liver 36, (12) 1774-1782 , DOI PEARL Thabet K, Asimakopoulos A, Shojaei M, Romero-Gomez M, Mangia A, Irving WL, Berg T, Dore GJ, Grønbæk H & Sheridan D 2016 'MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C' Nature communications 7, , DOI PEARL Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, Chan HLK, Irving WL, Sheridan D & Abate ML 2015 'Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease' NATURE COMMUNICATIONS 6, Author Site , DOI PEARL Bridge SH, Sheridan DA, Felmlee DJ, Crossey MME, Fenwick FI, Lanyon CV, Dubuc G, Seidah NG, Davignon J & Thomas HC 2015 'PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism' JOURNAL OF HEPATOLOGY 62, (4) 763-770 Author Site , DOI PEARL Sheridan DA, Bridge SH, Crossey MME, Felmlee DJ, Thomas HC, Neely RDG, Taylor-Robinson SD & Bassendine MF 2014 'Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency' Metabolic brain disease 29, (3) 625-634 , DOI